SGHT News and Press, Sight Sciences Inc. From 07/28/22

MENLO PARK, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced it will report financial results for the ...

MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced the appointment of Tamara Fountain, M.D. to its Bo...

Gainers: Seritage Growth Properties ( SRG ) +72% . Aditxt ( ADTX ) +70% . Humanigen ( HGEN ) +35% . Clovis Oncology ( CLVS ) +30% . MyMD Pharmaceuticals ( MYMD ) +27% . Oramed Pharmaceuticals ( ORMP ) +26% . Kura ...

iRhythm Technologies ( NASDAQ: IRTC ), a maker of electrocardiogram (ECG) monitoring products, added ~11% in the pre-market Friday after the company issued its comments on the Medicare reimbursement rates proposed for 2023. The Centers for Medicare and Medicaid Services ...

Shares of ophthalmic medical device concern Sight Sciences, Inc. have fallen 55% from their IPO pricing and 70% from their all-time high as the market shuns high-growth, profitless stocks. Owing to this decline, the company now trades at 4x FY22E sales net of net cash, even though tha...

Suppression of diurnal, or daily, fluctuations in IOP, is a significant and independent risk factor for the progression of glaucoma These 12-month outcomes were also confirmed by results from a subset of the study, assessing the Hispanic patient population MENLO PARK...

MENLO PARK, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced plans to participate in the upcoming Piper Sandler V...

The shares of Humacyte (NASDAQ:HUMA) are trading sharply lower on Monday after Piper Sandler downgraded the clinical-stage biotech to Underweight from Overweight expecting weakness in the near-term and citing attractiveness in the commercial-stage companies. The analysts led by Matt O'Brien c...

The following slide deck was published by Sight Sciences, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Sight Sciences, Inc. 2022 Q1 - Results - Earnings Call Presentation

Sight Sciences, Inc (SGHT) Q1 2022 Results Conference Call May 10, 2022 04:30 PM ET Company Participants Philip Taylor - Investor Relations Paul Badawi - Co-Founder and Chief Executive Officer Jesse Selnick - Chief Financial Officer Shawn O'Neil - Chief Commercial Officer Conference Call Part...